FI830011A0 - Foerfarande foer framstaellning av en inklusionskomplex av n-/1-fenyl-etyl/-3,3-difenylpropylamin eller dess hydroklorid med cyklodextrin - Google Patents

Foerfarande foer framstaellning av en inklusionskomplex av n-/1-fenyl-etyl/-3,3-difenylpropylamin eller dess hydroklorid med cyklodextrin

Info

Publication number
FI830011A0
FI830011A0 FI830011A FI830011A FI830011A0 FI 830011 A0 FI830011 A0 FI 830011A0 FI 830011 A FI830011 A FI 830011A FI 830011 A FI830011 A FI 830011A FI 830011 A0 FI830011 A0 FI 830011A0
Authority
FI
Finland
Prior art keywords
inklusionskomplex
diphenylpropylamine
hydrochlorides
cyclodextrin
phenyl
Prior art date
Application number
FI830011A
Other languages
English (en)
Other versions
FI67390B (fi
FI830011L (fi
FI67390C (fi
Inventor
Jozsef Szejtli
Agnes Stadler
Maria Vikmon
Dezsoe Korbonits
Sandor Virag
Istvan Turcsan
Pal Kiss
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI830011L publication Critical patent/FI830011L/fi
Publication of FI830011A0 publication Critical patent/FI830011A0/fi
Publication of FI67390B publication Critical patent/FI67390B/fi
Application granted granted Critical
Publication of FI67390C publication Critical patent/FI67390C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI830011A 1981-05-12 1983-01-03 Foerfarande foer framstaellning av en inklusionskomplex av n-(1-fenyletyl)-3,3-difenylpropylamin eller dess hydroklorid me cyklodextrin FI67390C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU128681 1981-05-12
HU811286A HU183430B (en) 1981-05-12 1981-05-12 Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
PCT/HU1982/000024 WO1982004052A1 (en) 1981-05-12 1982-05-12 Method for the preparation of inclusion complexes derived from n-(1-phenyle-ethyle)-3,3-diphenyle-propylamine respectively from the hydrochloryde thereof and from cyclodextrine
HU8200024 1982-05-12

Publications (4)

Publication Number Publication Date
FI830011L FI830011L (fi) 1983-01-03
FI830011A0 true FI830011A0 (fi) 1983-01-03
FI67390B FI67390B (fi) 1984-11-30
FI67390C FI67390C (fi) 1985-03-11

Family

ID=10953697

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830011A FI67390C (fi) 1981-05-12 1983-01-03 Foerfarande foer framstaellning av en inklusionskomplex av n-(1-fenyletyl)-3,3-difenylpropylamin eller dess hydroklorid me cyklodextrin

Country Status (6)

Country Link
US (1) US4518588A (fi)
EP (1) EP0078820B1 (fi)
DE (1) DE3277816D1 (fi)
FI (1) FI67390C (fi)
HU (1) HU183430B (fi)
WO (1) WO1982004052A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3372705D1 (en) * 1982-04-30 1987-09-03 Takeda Chemical Industries Ltd Pharmaceutical composition and its use
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
HU193933B (en) * 1984-06-08 1987-12-28 Nitrokemia Ipartelepek Herbicide or plant growth stimulating agent comprising beta-cyclodextrin complex of benzolsulphonylurea derivative and process for preparing the active substances
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
EP0261719A3 (en) * 1986-09-23 1990-10-10 Akzo N.V. Thermochemiluminescent cyclodextrin complexes
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
WO1989006978A1 (en) * 1988-02-05 1989-08-10 Schering Aktiengesellschaft Berlin Und Bergkamen Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
RU2147574C1 (ru) * 1991-08-23 2000-04-20 Эн-Пи-Эс Фармасьютикалз, Инк. Арилалкиламины, композиции, способы лечения и диагностики, способы идентификации соединения
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ZA955582B (en) * 1994-07-06 1996-02-26 Group Services Proprietary Lim Inclusion complexes of ranitidine
DK1203761T3 (da) 1994-12-08 2005-04-11 Nps Pharma Inc Calciumreceptoraktive forbindelser
DK0907631T3 (da) 1996-05-01 2003-09-22 Nps Pharma Inc Uorganiske ionreceptoraktive forbindelser
AU2001255709A1 (en) * 2000-05-11 2001-11-20 Eastman Chemical Company Acylated cyclodextrin guest inclusion complexes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553191A (en) * 1968-05-21 1971-01-05 Cpc International Inc Aminoethyl cyclodextrin and method of making same
JPS52121084A (en) * 1976-04-05 1977-10-12 Morogata Naoya Cyclodextrin inclusion compound and process for preparting the same
HU176215B (en) * 1978-01-27 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
US4407795A (en) * 1981-07-16 1983-10-04 American Cyanamid Company Inclusion compound of p-hexadecylamino benzoic acid in cyclodextrin and method of use

Also Published As

Publication number Publication date
FI67390B (fi) 1984-11-30
FI830011L (fi) 1983-01-03
FI67390C (fi) 1985-03-11
US4518588A (en) 1985-05-21
EP0078820B1 (de) 1987-12-09
EP0078820A1 (de) 1983-05-18
HU183430B (en) 1984-05-28
WO1982004052A1 (en) 1982-11-25
EP0078820A4 (de) 1984-11-23
DE3277816D1 (en) 1988-01-21

Similar Documents

Publication Publication Date Title
FI830011L (fi) Foerfarande foer framstaellning av en inklusionskomplex av n-/1-fenyl-etyl/-3,3-difenylpropylamin eller dess hydroklorid med cyklodextrin
FI86251B (fi) Foerfarande foer inkapsling av en svagt sur eller svagt basisk organisk foerening.
FI843031A (fi) Anordning foer vridstyv foerbindelse av i en robotarm eller liknande ingaoende element.
NO823087L (no) Forbindelseselement.
FI843083A0 (fi) Snabbt frigoerande fast preparat av en dihydropyridinfoerening.
FI833807A (fi) Foerfarande foer utredning av aemnets eller magnetfaeltets egenskaper.
DE3485010D1 (de) Luftreifen.
NO821827L (no) Taksluk eller lignende for en bygning.
FI833661A (fi) Anordning foer foerbaettring av stabiliteten av traktor eller arbetsmaskin.
NL173488C (nl) Velgprofileerinrichting.
IT8220897A0 (it) Parte termoplastica stampata con giunture riduttrici di sollecitazioni.
IT8422147A0 (it) Pneumatico per motocicli.
DK550982A (da) Kniv med boelgeskaer
FI834434A0 (fi) Foerfarande foer spaonbildande, avskiljande eller noetande bearbetning av metaller
FI863316A0 (fi) Foerfarande foer tillverkande av ett enhetligt, elektrisk stroem transmitterande element foer monopolariska eller bipolariska filterpresstypiska elektrokemiska cellenheter.
FI843731L (fi) Foerfarande foer framstaellning av reaktiva, kolrika massor eller delar.
FI834719A0 (fi) Anordning foer tillverkning av spaonskivor, fiberskivor eller liknande
FI841665A0 (fi) Anordning foer mottagande av en julgran, ett parasoll eller dylikt.
KR840002715U (ko) 덧테쇠
NO862513L (no) Innretning for forbindelse av en borstreng med et roer eller lignende.
FI841162A0 (fi) Understoed, understoedsplatta eller liknande av betong.
FI823110L (fi) Foerfarande foer framstaellning av en brandhaemmande eller obraennbar spaonplatta, saerskilt foer beklaedningsaendamaol
FI834533A0 (fi) Behaollare, saerskilt blomkruka eller liknande
DE3676702D1 (de) Aerodynamisches profil.
IT8323824V0 (it) Profilato, particolarmente studiato per la realizzazione di strutture portanti per resistenze a telaio ed a cassetta.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT.